SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000926617-22-000039
Filing Date
2022-06-02
Accepted
2022-06-02 09:10:31
Documents
12
Period of Report
2022-06-01
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K awh-20220602x8k.htm   iXBRL 8-K 83417
  Complete submission text file 0000926617-22-000039.txt   206875

Data Files

Seq Description Document Type Size
2 EX-101.SCH awh-20220602.xsd EX-101.SCH 2548
3 EX-101.LAB awh-20220602_lab.xml EX-101.LAB 15610
4 EX-101.PRE awh-20220602_pre.xml EX-101.PRE 11192
6 EXTRACTED XBRL INSTANCE DOCUMENT awh-20220602x8k_htm.xml XML 4966
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 22989363
SIC: 2835 In Vitro & In Vivo Diagnostic Substances